Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery Elliott Bennett-Guerrero, MD, Thomas F. Slaughter, MD, William D. White, MPH, Ian J. Welsby, MD, Charles S. Greenberg, MD, Habib El-Moalem, PhD, Thomas L. Ortel, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 130, Issue 6, Pages 1567-1572 (December 2005) DOI: 10.1016/j.jtcvs.2005.07.052 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Major complication rate and mean Parsonnet risk score by preoperative serum anti-heparin/PF4 antibody result. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1567-1572DOI: (10.1016/j.jtcvs.2005.07.052) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Major complication and mean Parsonnet risk score by preoperative serum anti-heparin/PF4 antibody result. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1567-1572DOI: (10.1016/j.jtcvs.2005.07.052) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions